CCXI Gross Margin

The Gross Margin of ChemoCentryx Inc (CCXI) is 99.06%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CCXI Gross Margin - Historical Value

Date	Value
2021-12-31	99.06%

CCXI Gross Margin - Peers Comparison

Ticker	Name	Value
GILD	Gilead Sciences Inc	78.26%
LEGN	Legend Biotech Corp	62.60%
LGND	Ligand Pharmaceuticals Inc	93.37%
RLAY	Relay Therapeutics Inc	7775.20%
RUBY	Rubius Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
ARNA	Arena Pharmaceuticals Inc	78.92%
IGMS	IGM Biosciences Inc	7775.20%
IOVA	Iovance Biotherapeutics Inc	24.43%
DCPH	Deciphera Pharmaceuticals Inc	97.72%
MRNA	Moderna Inc	70.06%
NTLA	Intellia Therapeutics Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
ALLO	Allogene Therapeutics Inc	7775.20%
ALXO	ALX Oncology Holdings Inc	9.32%
BHVN	Biohaven Ltd	72.18%
950220.KQ	Neoimmunetech Inc	7775.20%
ADCT	ADC Therapeutics SA	91.60%
FOLD	Amicus Therapeutics Inc	89.98%
VIE	Viela Bio Inc	82.49%
950200.KQ	Psomagen Inc	23.13%
IMCR	Immunocore Holdings PLC	99.12%
KYMR	Kymera Therapeutics Inc	7775.20%
RVMD	Revolution Medicines Inc	7775.20%
ABBV	Abbvie Inc	69.99%
FGEN	FibroGen Inc	47.47%
PRLD	Prelude Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
INO	Inovio Pharmaceuticals Inc	60.13%
RCUS	Arcus Biosciences Inc	7775.20%
SWTX	SpringWorks Therapeutics Inc	93.45%
AMGN	Amgen Inc	61.53%
AMTI	Applied Molecular Transport Inc.	7775.20%
APLS	Apellis Pharmaceuticals Inc	84.93%
GBT	Global Blood Therapeutics Inc	98.30%